| 1 |
NCT02866656 |
Not yet recruiting |
The Clinical Research of Low Intensity Continuous Ultrasonic on Lower Limb Arteriosclerosis Occlusion（ASO） Syndrome |
|
- Other: Conventional conservative treatment
- Device: therapeutic ultrasound
|
Interventional |
Not Applicable |
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Improvement of ankle brachial ratio at 4 weeks of treatment
- Improvement of local skin temperature at 4 weeks of treatment
- Recovery of ultrasonic blood vessels at 4 weeks of treatment
- (and 4 more...)
|
90 |
All |
35 Years to 70 Years (Adult, Senior) |
NCT02866656 |
XH-16-007 |
|
September 2016 |
October 2018 |
October 2018 |
August 15, 2016 |
August 15, 2016 |
|
|
| 2 |
NCT02849405 |
Recruiting |
Evaluation of the Capacity of a Camera to Identify Signs of Arteriosclerosis in Retinal Arterioles |
|
- Device: MHRC: Metabolic Hyperspectral Retinal Camera
|
Interventional |
Not Applicable |
- Jean-Claude Tardif
- Montreal Heart Institute
- Polytechnique Montréal
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Spectral intensity measures to visible and near infrared light around retinal arterioles in 30 patients with clearly defined atherosclerosis and 30 controls.
|
60 |
All |
18 Years and older (Adult, Senior) |
NCT02849405 |
ICM-ART-P |
|
December 21, 2016 |
October 2018 |
October 2018 |
July 29, 2016 |
March 5, 2018 |
|
- Montreal Heart Institute
Montreal, Quebec, Canada
|
| 3 |
NCT02877173 |
Recruiting |
A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans |
- Arteriosclerosis Obliterans
|
- Drug: Alprostadil Liposomes for Injection
- Drug: Alprostadil Injection
|
Interventional |
Phase 2 |
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Change from baseline in distance of asymptomatic disease and claudication after 3 weeks of treatment.
- Change from baseline in maximun distance of claudication after 3 weeks of treatment.
- Change from baseline in distance of asymptomatic disease and claudication and in maximum distance of claudication after 2 weeks of treatment.
- (and 2 more...)
|
160 |
All |
40 Years to 80 Years (Adult, Senior) |
NCT02877173 |
YPH-ZZTP-L01 |
|
August 2016 |
July 2017 |
December 2017 |
August 24, 2016 |
March 10, 2017 |
|
- Xuanwu Hospital Capital Medical University
Beijing, China
|
| 4 |
NCT02107170 |
Recruiting |
Effects of Anesthetics on Postoperative Cognitive Function of Patients Undergoing Endovascular Repair of Aortic Aneurysm and Endovascular Treatment of Arteriosclerosis Obliterans of Lower Extremities. |
- Endovascular Repair of Aortic Aneurysm
- Endovascular Treatment of Arteriosclerosis Obliterans of Lower Extremities
|
- Drug: Sevoflurane
- Drug: Propofol
- Drug: Remifentanil
|
Interventional |
Phase 4 |
- Tao Zhang
- First Affiliated Hospital, Sun Yat-Sen University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Prevention
|
- Number of patients with postoperative cognitive dysfunction
- Changes in plasma levels of VEGF, TGF-1, TNF-α, IL-1β, and IL-6 (a composite outcome measure)
|
400 |
All |
18 Years and older (Adult, Senior) |
NCT02107170 |
VIAEV |
|
February 2014 |
December 2018 |
|
April 8, 2014 |
April 25, 2017 |
|
- First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China
|
| 5 |
NCT02639962 |
Recruiting |
Characteristics of Culprit Lesion and Changes in Plaque Composition. A Dual Energy Cardiac CT Study |
- Coronary Arteriosclerosis
|
|
Observational |
|
- Odense University Hospital
|
Other |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
- Description and characteristics of culprit lesion by DECT. (z-value)
- Describe if the culprit lesion contains 1: soft 2: mixed or 3: calcified tissue
- Measure the volume of the culprit lesion
- (and 6 more...)
|
135 |
All |
18 Years to 90 Years (Adult, Senior) |
NCT02639962 |
Challenge |
S-20130009 |
September 2014 |
September 2017 |
September 2017 |
December 28, 2015 |
June 1, 2017 |
|
- Department of Medical Research, OUH, Svendborg
Svendborg, Denmark
|
| 6 |
NCT02919124 |
Recruiting |
Epicardial Echocardiography of Coronary Anastomoses Using the Echoclip Device |
- Coronary Arteriosclerosis
|
|
Interventional |
Not Applicable |
- Aalborg Universitetshospital
- Aalborg University
- Medistim ASA
|
Other / Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Quality of periferal coronary artery bypass anastomotic structures
- Automatic quality control of periferal coronary artery bypass anastomotic structures
|
100 |
All |
18 Years and older (Adult, Senior) |
NCT02919124 |
0089Y |
|
September 2016 |
December 2018 |
December 2018 |
September 29, 2016 |
November 29, 2017 |
|
- Aalborg University Hospital
Aalborg, Denmark
|
| 7 |
NCT00540761 |
Recruiting |
Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique |
- Coronary Arteriosclerosis
|
|
Interventional |
Phase 1 |
- Massachusetts General Hospital
- National Heart, Lung, and Blood Institute (NHLBI)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Screening
|
- Determine prevalence of vulnerable plaques
- Safety of OFDI imaging
|
320 |
All |
21 Years and older (Adult, Senior) |
NCT00540761 |
2005-P000646
R01HL076398 |
|
May 2007 |
December 2018 |
December 2018 |
October 8, 2007 |
January 25, 2018 |
|
- Massachusetts General Hospital
Boston, Massachusetts, United States - Lahey Clinic
Burlington, Massachusetts, United States - Columbia Presbyterian Medical Center
New York, New York, United States
|
| 8 |
NCT02490397 |
Recruiting |
Impact of Daylight on Patients With Acute Myocardial Infarction |
- Coronary Arteriosclerosis
- Myocardial Infarction
|
- Other: Day Light
- Other: Room Light
|
Interventional |
Not Applicable |
- University of Colorado, Denver
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change of Period 2 (Per2) protein levels
|
30 |
All |
18 Years to 90 Years (Adult, Senior) |
NCT02490397 |
13-1607 |
|
July 2015 |
December 2018 |
July 2019 |
July 3, 2015 |
December 18, 2017 |
|
- University of Colorado
Denver, Colorado, United States
|
| 9 |
NCT02305862 |
Recruiting |
A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic Plaques |
- Arteriosclerosis
- Diabetes Mellitus
- Lipid Disorder
|
- Drug: Rosuvastatin 5mg
- Drug: Rosuvastatin 20mg
|
Interventional |
Not Applicable |
- Capital Medical University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- To evaluate whether 26 weeks of treatment with 5/20mg rosuvastatin results in regression of carotid atherosclerotic plaques as measured by CE-MRI
- major adverse cardiovascular events
- To evaluate the change in lipid and lipoprotein levels as assessed by percentage change from baseline.
- (and 3 more...)
|
150 |
All |
18 Years to 75 Years (Adult, Senior) |
NCT02305862 |
AMARIROCAP |
|
January 2013 |
December 2016 |
July 2017 |
December 3, 2014 |
July 21, 2016 |
|
- Beijing Tiantan Hospital, Capital Medical University
Beijing, China
|
| 10 |
NCT02501018 |
Recruiting |
Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI) |
- Critical Limb Ischemia (CLI)
|
- Biological: CLBS12
- Drug: SOC
|
Interventional |
Phase 2 |
- Caladrius Biosciences, Inc.
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Time to continuous CLI-free status
|
35 |
All |
20 Years to 80 Years (Adult, Senior) |
NCT02501018 |
CLBS12-01 |
|
November 1, 2017 |
January 2020 |
July 2020 |
July 17, 2015 |
February 12, 2018 |
|
- Shonan Kamakura General Hospital
Kamakura, Japan - Kobe City Medical Center General Hospital
Kobe, Japan - Tokyo Women's Medical University
Tokyo, Japan
|
| 11 |
NCT02991703 |
Not yet recruiting |
Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children |
- Cardiovascular Diseases
- Arteriosclerosis
- Atherosclerosis
|
- Device: pOpmètre®
- Device: Sphygmocor
|
Interventional |
Not Applicable |
- Nantes University Hospital
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Difference between the two simultaneous measurements of velocity of the pulse wave by the pOpmeter® and the Sphygmocor®.
|
60 |
All |
4 Years to 8 Years (Child) |
NCT02991703 |
RC16_0161 |
EPIPOP |
December 2016 |
November 2017 |
November 2017 |
December 13, 2016 |
December 13, 2016 |
|
|
| 12 |
NCT03315234 |
Recruiting |
Correlation of Genetic Polymorphisms and Clinical Parameters With the Complexity of Coronary Artery Disease |
- Coronary Artery Disease
- Cardiovascular Risk Factor
- Coronary Arteriosclerosis
|
- Genetic: SNPs associated with CAD
|
Observational |
|
- Aristotle University Of Thessaloniki
- LABNET IAE - Private Reference Diagnostic Laboratory
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Relationship between genetic risk variants and the SYNTAX score [All-comers population]
- MACCEs
- Predictive value of combining a Genetic Risk Score & SYNTAX score for the prediction of 1-year MACCEs
- (and 7 more...)
|
270 |
All |
18 Years to 90 Years (Adult, Senior) |
NCT03315234 |
CIP_PhD Rampidis Georgios_1.1 |
|
September 1, 2016 |
June 30, 2018 |
December 31, 2018 |
October 20, 2017 |
February 8, 2018 |
|
- AHEPA University Hospital
Thessaloníki, Greece
|
| 13 |
NCT01399385 |
Recruiting |
New Heart Imaging Techniques to Evaluate Possible Heart Disease |
- Healthy
- Obesity
- Diabetes
- (and 2 more...)
|
|
Observational |
|
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institutes of Health Clinical Center (CC)
|
NIH |
|
- Coronary segmental involvement scores
|
99999999 |
All |
18 Years and older (Adult, Senior) |
NCT01399385 |
110168
11-DK-0168 |
|
July 20, 2011 |
|
|
July 21, 2011 |
April 20, 2018 |
|
- National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
|
| 14 |
NCT03414840 |
Not yet recruiting |
Assessment of Change in Atherosclerotic Plaque by Serial CCTA |
- Coronary Artery Disease
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Coronary Arteriosclerosis
|
|
Observational |
|
- Yonsei University
- Chong Kun Dang Pharmaceutical Corp.
|
Other / Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Difference in percent change of total atheroma volume assessed by CCTA between statin-taking and statin-naïve group
- Change of total atheroma volume at 24 months compared with baseline total atheroma volume
|
400 |
All |
19 Years and older (Adult, Senior) |
NCT03414840 |
2017-2669-001 |
ACROSS |
March 1, 2018 |
February 28, 2020 |
October 31, 2020 |
January 30, 2018 |
January 30, 2018 |
|
|
| 15 |
NCT01774058 |
Recruiting |
The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation |
- Diabetes
- Arteriosclerosis
- Peripheral Arterial Occlusive Disease
- Neuropathy
|
|
Interventional |
Phase 2 |
- Prim PD Dr Afshin Assadian
- Wilhelminenspital Vienna
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- The measurement of the blood flow volume is done with the Sono TT FlowLab (em-Tec GmbH, Munich) ultrasound instrument on the common femoral artery in diabetics and non-diabetics after ilomedin administration.
|
100 |
All |
18 Years and older (Adult, Senior) |
NCT01774058 |
ILOFLOW2.0 |
ILOFLOW |
October 2012 |
June 2018 |
June 2018 |
January 23, 2013 |
February 15, 2018 |
|
- Department of vascular and endovascular surgery, Georg Hagmüller Institute for Vascular Research Wilhelminenhospital
Vienna, Austria
|
| 16 |
NCT03085823 |
Recruiting |
The All-comers Sirolimus-coated Balloon European Registry |
- Percutaneous Coronary Intervention
- Angioplasty, Balloon, Coronary
- Coronary Angioplasty, Transluminal Balloon
- Arteriosclerosis, Coronary
|
- Device: Sirolimus Coated Balloon
|
Observational |
|
- Fatebenefratelli and Ophthalmic Hospital
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Target lesion revascularization
- Angiographic success
- procedural success
- (and 2 more...)
|
900 |
All |
18 Years and older (Adult, Senior) |
NCT03085823 |
fbf001 |
EASTBOURNE |
September 2016 |
December 2019 |
January 2020 |
March 21, 2017 |
March 21, 2017 |
|
- Unita' Operativa di Cardiologia
Milano, Italy
|
| 17 |
NCT02840786 |
Recruiting |
Clinical Study of Stent Versus Direct Atherectomy to Treat Arteriosclerosis Occlusive Disease of Lower Extremity |
|
- Device: plaque excision system
- Device: Stent
|
Interventional |
Not Applicable |
- Xuanwu Hospital, Beijing
- Beijing Friendship Hospital
- Beijing Chao Yang Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- 12-month Primary Patency Rate
- 12-month Limb Salvage Rate
- Index Limb Ischemia at 6-month Follow up
- (and 2 more...)
|
120 |
All |
18 Years and older (Adult, Senior) |
NCT02840786 |
XuanwuH16 |
|
January 2016 |
January 2018 |
January 2019 |
July 21, 2016 |
July 21, 2016 |
|
- Gu Yong Quan
Beijing, Beijing, China
|
| 18 |
NCT03037411 |
Recruiting |
A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries |
- Arterial Occlusive Diseases
- Atherosclerosis
- Vascular Diseases
- Arteriosclerosis
|
- Device: Peripheral stenting
|
Observational |
|
- Boston Scientific Corporation
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Health care costs
- Quality of Life Improvement
- Walking Improvement
- (and 3 more...)
|
500 |
All |
18 Years and older (Adult, Senior) |
NCT03037411 |
S2346 |
REGAL |
December 2016 |
January 2020 |
January 2020 |
January 31, 2017 |
April 12, 2018 |
|
- Medizinische Universität Graz
Graz, Austria - ZOL Genk
Genk, Limburg, Belgium - Regionaal Ziekenhuis Heilig Hart Tienen
Tienen, Vlaams-Brabant, Belgium - (and 20 more...)
|
| 19 |
NCT02921230 |
Recruiting |
Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery |
- Arterial Occlusive Diseases
- Atherosclerosis
- Vascular Diseases
- Arteriosclerosis
|
- Device: Peripheral stenting
|
Interventional |
Not Applicable |
- Boston Scientific Corporation
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Primary Patency at 12 months post-procedure
- Walking Improvement
- Change in quality of life
- (and 3 more...)
|
750 |
All |
18 Years and older (Adult, Senior) |
NCT02921230 |
S2366 |
EMINENT |
October 2016 |
June 2019 |
May 2021 |
October 3, 2016 |
April 12, 2018 |
|
- LKH Innsbruck
Innsbruck, Austria - Klinikum Klagenfurt
Klagenfurt, Austria - Allgemeines Krankenhaus Wien
Vienna, Austria - (and 65 more...)
|
| 20 |
NCT02933957 |
Recruiting |
Chinese Arteriosclerosis Series Evaluation-She Minority Study |
|
|
Observational |
|
- Peking University Shougang Hospital
- MinDong Hospital of Ningde City
|
Other |
- Observational Model: Ecologic or Community
- Time Perspective: Cross-Sectional
|
- value of brachial ankle pulse wave velocity
- Percentage of flow mediated dilation
- Value of arterial elasticity including stiffness coefficient β, pressure strain elastic coefficient, arterial compliance
- (and 3 more...)
|
300 |
All |
18 Years to 90 Years (Adult, Senior) |
NCT02933957 |
PUShougangH |
CASE-SMS |
January 2015 |
October 2017 |
|
October 14, 2016 |
October 14, 2016 |
|
- Peking University Shougang Hospital
Beijing, Beijing, China
|
| 21 |
NCT03310671 |
Recruiting |
Aortic Stenosis in Subjects With Heterozygous Familial Hypercholesterolemia on Prolonged Treatment With Statins |
- Aortic Stenosis
- Arteriosclerosis
- Familial Hypercholesterolemia
- Conventional Transthoracic Echocardiogram
|
- Procedure: Echocardiogram
|
Observational |
|
- Instituto Aragones de Ciencias de la Salud
|
Other |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
- Differences in age-adjusted prevalence of EA assessed by transthoracic echocardiography between cases and controls
- Differences in age-adjusted prevalence of AD assessed by transthoracic echocardiography between cases and controls
- Difference in aortic surface between cases and controls
- (and 2 more...)
|
900 |
All |
55 Years and older (Adult, Senior) |
NCT03310671 |
C.I.PI17/0256 |
|
July 18, 2017 |
July 18, 2018 |
July 18, 2018 |
October 16, 2017 |
October 16, 2017 |
|
- Fernando Civeira Murillo
Zaragoza, Spain
|
| 22 |
NCT02975648 |
Not yet recruiting |
Education Model for Cardiac Patients |
- Coronary Artery Disease
- Coronary Disease
- Arteriosclerosis
- Cardiovascular Diseases
|
- Behavioral: educational model + follow up
- Behavioral: usual care
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Change from baseline in level (frequency and time spent) of physical activity at six months
- Change from baseline in symptoms of anxiety and depression at six months
- Change from baseline in perceived health status at six months
- Change from baseline in self-efficacy at six months
|
156 |
All |
18 Years and older (Adult, Senior) |
NCT02975648 |
51805715.0.0000.5393 |
|
January 2017 |
December 2018 |
October 2019 |
November 29, 2016 |
November 29, 2016 |
|
- Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Ribeirao Preto, São Paulo, Brazil
|
| 23 |
NCT02428582 |
Recruiting |
Covered Stents Versus Bare-Metal Stents |
- Gastrointestinal Vascular Conditions
- Arteriosclerosis
- Lifestyle-related Condition
- (and 3 more...)
|
- Device: Covered stent (Atrium Type V12)
- Device: Bare stent (Brand Cordis Type Palmaz Blue)
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- The difference of primary and secondary patency rates of covered stents versus bare-metal stents to treat atherosclerotic CGI disease.
- The freedom from restenosis after 6-, 12- and 24- months after stent implantation
- The freedom from symptom recurrence after 6-, 12- and 24- months after stent implantation
- (and 3 more...)
|
84 |
All |
18 Years and older (Adult, Senior) |
NCT02428582 |
MEC-2013-476 |
|
May 2016 |
November 2018 |
November 2018 |
April 29, 2015 |
January 31, 2018 |
|
- ErasmusMC
Rotterdam, Zuid Holland, Netherlands
|
| 24 |
NCT01777503 |
Recruiting |
The Elderly ACS II Trial |
- Acute Coronary Syndrome
- Coronary Arteriosclerosis
- Myocardial Ischemia
- Cardiovascular Diseases
|
- Drug: prasugrel
- Drug: Clopidogrel
|
Interventional |
Phase 4 |
- Arcispedale Santa Maria Nuova-IRCCS
- ANMCO Italian Association of Hospital Cardiologist
- Italian Society of Invasive Cardiology
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- The composite of all-cause mortality, myocardial infarction (MI), disabling stroke and re-hospitalization for cardiovascular causes or bleeding within one year
- The composite of burden of recurrent cardiovascular (CV) events, CV mortality, all-cause mortality and MI, major bleeding, any stroke, total number of days spent in hospital.
|
2000 |
All |
75 Years and older (Senior) |
NCT01777503 |
EudraCT Number: 2012-002882-37 |
|
November 2012 |
August 2017 |
December 2017 |
January 29, 2013 |
October 21, 2016 |
|
- Azienda Ospedaliera "Ospedale Civile di Legnano"
Legnano, MI, Italy - Arcispedale Santa Maria Nuova- IRCCS
Reggio Emilia, Italy
|
| 25 |
NCT00117936 |
Not yet recruiting |
Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease |
- Coronary Disease
- Coronary Heart Disease
- Myocardial Ischemia
- Coronary Arteriosclerosis
|
- Drug: Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141)
- Drug: Human Recombinant Fibroblast Growth Factor-1 (FGF1-141)
|
Interventional |
Phase 2 |
- CardioVascular BioTherapeutics, Inc.
|
Industry |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Change in cardiac perfusion as measured by SPECT scan under stress conditions and change in vascular bed density at the sites of injections as determined by angiography
- Exercise treadmill test: time (or change in time) to onset of at least 1 mm additional horizontal or downsloping ST-segment depression, or time to ETT in the absence of at least 1 mm additional ST-segment depression due to pain (angina)
|
120 |
All |
25 Years to 75 Years (Adult, Senior) |
NCT00117936 |
CVBT-CHD07-01 |
ACORD |
September 30, 2019 |
September 30, 2021 |
September 30, 2022 |
July 11, 2005 |
January 25, 2018 |
|
- Princeton Baptist Medical Center
Birmingham, Alabama, United States - Mercy Gilbert Medical Center
Gilbert, Arizona, United States - Medical Center, University of California, San Diego
San Diego, California, United States - (and 7 more...)
|
| 26 |
NCT02315924 |
Recruiting |
Combined Coronary and Cerebral Angiography and Intervention for Coronary and Cerebrovascular Atherosclerosis |
- Coronary Stenosis
- Cerebral Stenosis
|
- Other: simultaneous coronary and cerebral intervention
- Other: staged coronary and cerebral intervention
|
Interventional |
Not Applicable |
- Capital Medical University
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- stroke
- acute myocardial infarction
- extracranial arterial stenosis
- (and 3 more...)
|
300 |
All |
20 Years to 80 Years (Adult, Senior) |
NCT02315924 |
COCCAICOCA |
|
March 2013 |
December 2016 |
December 2016 |
December 12, 2014 |
July 21, 2016 |
|
- Beijing Tiantan Hospital, Capital Medical University
Beijing, China
|
| 27 |
NCT03485495 |
Not yet recruiting
New |
Clinical Trial of Efficacy and Safety of Divaza in the Management of Oxidative Disturbances in Cerebral Atherosclerosis |
|
- Drug: Divaza
- Drug: Placebo
|
Interventional |
Phase 4 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in the mean resistance of lipoprotein (LP) to lipid peroxidation (LPO) from baseline to week 12
- Proportion of subjects with improved cognitive function (Montreal Cognitive Assessment score +1 and over) from baseline to week 12
|
124 |
All |
40 Years to 75 Years (Adult, Senior) |
NCT03485495 |
MMH-DV-010 |
|
April 2018 |
December 2020 |
December 2020 |
April 2, 2018 |
April 2, 2018 |
|
- Moscow City Clinical Hospital after V.M. Buyanov
Moscow, Russian Federation - Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Moscow, Russian Federation - Federal State Budget Scientific Institution "Scientific Center of Neurology"
Moscow, Russian Federation - (and 3 more...)
|
| 28 |
NCT03295773 |
Recruiting |
Morphologic Evolution and Remodeling of Intracranial Atherosclerosis: A Longitudinal Study by 3D-rotational Angiography |
- Ischemic Stroke
- Atheroscleroses, Cerebral
|
|
Observational |
|
- Chinese University of Hong Kong
|
Other |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- Morphologic Evolution and Remodeling of Intracranial Atherosclerosis
|
70 |
All |
18 Years to 80 Years (Adult, Senior) |
NCT03295773 |
crec no. 2015.623 |
|
August 22, 2016 |
December 31, 2019 |
June 30, 2020 |
September 28, 2017 |
September 28, 2017 |
|
- Chinese University of Hong Kong
Hong Kong, Hong Kong
|
| 29 |
NCT03291652 |
Recruiting |
Morphology of Advanced Symptomatic Cerebral Plaques With High Embolic Potential |
- Ischemic Stroke
- Atheroscleroses, Cerebral
|
- Diagnostic Test: DSA/3DRA
|
Observational |
|
- Chinese University of Hong Kong
|
Other |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
- The plaque morphology of high-risk IAD may be distinct from the silent ones.
|
140 |
All |
30 Years to 85 Years (Adult, Senior) |
NCT03291652 |
crec no. 2011.021 |
|
February 2010 |
December 20, 2020 |
December 31, 2020 |
September 25, 2017 |
September 25, 2017 |
|
- Chinese University of Hong Kong
Hong Kong, Hong Kong
|
| 30 |
NCT03208166 |
Recruiting |
Pilot Study of Pre-Ischemic Conditioning for Intracranial Atherosclerosis |
- Intracranial Atherosclerosis
|
- Device: Doctormate
- Other: Usual Care
|
Interventional |
Early Phase 1 |
- Medical University of South Carolina
- University of Southern California
- University of California, Los Angeles
- Augusta University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
|
10 |
All |
30 Years to 90 Years (Adult, Senior) |
NCT03208166 |
Pro00062831 |
PICASSO |
June 15, 2017 |
December 2017 |
December 2017 |
July 5, 2017 |
August 11, 2017 |
|
- Medical University of South Carolina
Charleston, South Carolina, United States
|
| 31 |
NCT02689037 |
Not yet recruiting |
Angioplasty and Stenting for Patients With Symptomatic Intracranial Atherosclerosis |
- Intracranial Atherosclerosis
|
- Procedure: Percutaneous transluminal angioplasty and stenting
- Drug: Aspirin plus clopidogrel
|
Interventional |
Phase 3 |
- The 476th Hospital of People's Liberation Army
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Proportion of patients with events of stroke or death
- the incidence of recurrent ischaemic stroke in the stenting-involved vascular territory
- neurological functional outcome by the Chinese version of National Institutes of Health Stroke Scale (C-NIHSS)
- Proportion of patients with adverse events
|
394 |
All |
18 Years to 70 Years (Adult, Senior) |
NCT02689037 |
12MA100 |
|
April 2016 |
December 2018 |
December 2019 |
February 23, 2016 |
April 5, 2016 |
|
|
| 32 |
NCT03349385 |
Recruiting |
Registry of Secondary Revascularization |
- Coronary Artery Disease Progression
- Coronary Artery Disease of Significant Bypass Graft
- Stent Stenosis
- (and 2 more...)
|
|
Observational |
|
- Hospital San Carlos, Madrid
- Laboratorios Farmacéuticos Rovi, S.A.
- S&H Medical Science Service
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Patient-oriented composite endpoint
- Rates of individual components of primary outcome
- Composite endpoint at 2 to 5 years
- (and 3 more...)
|
1000 |
All |
18 Years and older (Adult, Senior) |
NCT03349385 |
ROV-EPI-2017-01 |
REVASEC |
November 22, 2017 |
February 28, 2020 |
December 31, 2024 |
November 21, 2017 |
November 24, 2017 |
|
- Hospital Clinico San Carlos
Madrid, Spain - Hospital Clínico Universitario de Valladolid
Valladolid, Spain
|
| 33 |
NCT03471845 |
Recruiting |
RESOLUTE ONYX China Single Arm Study |
- Ischemic Heart Disease
- Stenotic Coronary Lesion
- Cardiovascular Diseases
- (and 2 more...)
|
- Device: Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
|
Interventional |
Not Applicable |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Target Lesion Failure (TLF)
- Device Success
- Lesion Success
- (and 12 more...)
|
585 |
All |
18 Years and older (Adult, Senior) |
NCT03471845 |
MDT16058RES004 |
|
March 30, 2018 |
September 30, 2020 |
September 30, 2024 |
March 21, 2018 |
April 5, 2018 |
|
- Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, China
|
| 34 |
NCT03466151 |
Recruiting |
RESOLUTE ONYX China RCT Study |
- Ischemic Heart Disease
- Stenotic Coronary Lesion
- Cardiovascular Diseases
- (and 2 more...)
|
- Device: Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
- Device: Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System
|
Interventional |
Not Applicable |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- In-stent Late lumen loss measured by quantitative coronary angiography (QCA)
- Device Success
- Lesion Success
- (and 12 more...)
|
550 |
All |
18 Years and older (Adult, Senior) |
NCT03466151 |
MDT16061RES005 |
|
April 12, 2018 |
September 30, 2020 |
November 30, 2024 |
March 15, 2018 |
April 13, 2018 |
|
- Shengjing Hospital of China Medical University
Shenyang, Liaoning, China - Fumwai Hospital, Chinese Academy of Medical Science
Beijing, China
|
| 35 |
NCT03253692 |
Recruiting |
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI) |
- Coronary Artery Disease
- Coronary Disease
- Myocardial Ischemia
- (and 2 more...)
|
|
Observational |
|
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institutes of Health Clinical Center (CC)
|
NIH |
- Observational Model: Case-Only
- Time Perspective: Cross-Sectional
|
- Determine radiation dose estimates of cardiac CT angiographies in daily practice
|
5000 |
All |
18 Years to 100 Years (Adult, Senior) |
NCT03253692 |
170146
17-H-0146 |
|
October 3, 2017 |
March 31, 2019 |
March 31, 2019 |
August 18, 2017 |
April 5, 2018 |
|
- Long Beach Veterans Affairs
Long Beach, California, United States - Los Angeles Biomedical Research Institute
Los Angeles, California, United States - George Washington University School of Medicine
Washington, District of Columbia, United States - (and 13 more...)
|
| 36 |
NCT03280433 |
Recruiting |
Influence of EPICardial Adipose Tissue in HEART Diseases: EPICHEART Study |
- Coronary Artery Disease
- Coronary Arteriosclerosis
- Atrial Fibrillation
- (and 2 more...)
|
- Other: Aortic valve replacement
|
Observational |
|
- Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
- Universidade do Porto
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- New onset atrial fibrillation
- Left atrial remodelling by transthoracic echocardiography and magnetic resonance imaging
- Frailty syndrome according to Fried et al. scale
- (and 3 more...)
|
500 |
All |
18 Years and older (Adult, Senior) |
NCT03280433 |
SFRH/BD/104369/2014 |
EPICHEART |
September 1, 2014 |
November 25, 2015 |
November 25, 2018 |
September 12, 2017 |
September 14, 2017 |
|
- Centro Hospitalar de Vila Nova de Gaia/Espinho
Vila Nova de Gaia, Porto, Portugal - Faculty of Medicine of Porto
Porto, Portugal
|
| 37 |
NCT03008798 |
Not yet recruiting |
Prevention for the Restenosis of Intracranial Artery Stent Implantation Treated With Herbal Medicine C117 |
- Occlusion and Stenosis of Unspecified Cerebral Artery
|
- Drug: Herbal Medicine C-117
- Drug: The Placebo of Herbal Medicine C-117
|
Interventional |
Phase 2 |
- Guangzhou University of Traditional Chinese Medicine
- Liaocheng People's Hospital
- Liaoning thrombus treatment center of integrated chinese and western medicine
- Zhongshan People's Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Prevention
|
- the total number of all-cause mortality and all-cause stroke within 12 months
- The rate of intracranial in-stent restenosis
- The complications of intracranial in-stent restenosis
- (and 3 more...)
|
180 |
All |
18 Years to 80 Years (Adult, Senior) |
NCT03008798 |
2014A020221074 |
PRISIT |
January 2017 |
December 2019 |
December 2019 |
January 2, 2017 |
January 2, 2017 |
|
|
| 38 |
NCT03496948 |
Not yet recruiting
New |
Telephone Health Coaching and Remote Exercise Monitoring for Peripheral Artery Disease |
- Peripheral Artery Disease
- Atherosclerosis
- Peripheral Arterial Disease
- (and 4 more...)
|
|
Interventional |
Not Applicable |
- Universitätsklinikum Hamburg-Eppendorf
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in score on Walking Impairment Questionnaire (WIQ)
- Change in total health care costs
- Change in score on Walking Estimated Limitation Calculated by History (WELCH) questionnaire
- (and 11 more...)
|
4630 |
All |
35 Years to 80 Years (Adult, Senior) |
NCT03496948 |
tegecoach
01NVF17013 |
TeGeCoach |
April 23, 2018 |
October 15, 2020 |
October 15, 2020 |
April 12, 2018 |
April 12, 2018 |
|
- TK statutory health insurance
Hamburg, Germany - KKH statutory health insurance
Hannover, Germany - Mhplus Statutory Health Insurance
Nürnberg, Germany
|
| 39 |
NCT02458755 |
Recruiting |
Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis |
- Stroke
- Intracranial Atherosclerosis
|
- Drug: High-dose statin: Atorvastatin 40mg or Rosuvastatin 20mg
|
Interventional |
Phase 4 |
- Samsung Medical Center
- Don-A Pharmaceutical, Seoul, South Korea
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Changes in vascular remodeling before and after the statin treatment
- Elevated liver function test or muscle enzyme levels
- Recurrent stroke/Transient ischemic attack
- (and 2 more...)
|
80 |
All |
20 Years and older (Adult, Senior) |
NCT02458755 |
SMC 2011-12-053 |
STAMINA-MRI |
February 2012 |
June 2018 |
June 2018 |
June 1, 2015 |
April 26, 2017 |
|
- Oh Young Bang
Seoul, Korea, Republic of
|
| 40 |
NCT01819597 |
Recruiting |
Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis |
- Intracranial Arterial Stenosis
- Intracranial Atherosclerosis
- Ischemic Stroke
- Cerebral Angiogenesis
|
- Procedure: Encephaloduroarteriosynangiosis (EDAS)
|
Interventional |
Phase 2 |
- Cedars-Sinai Medical Center
- National Institutes of Health (NIH)
|
Other / NIH |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Stroke or death after enrollment
- Stroke or death in the territory of qualifying artery
- Any stroke or death
- (and 6 more...)
|
55 |
All |
30 Years to 80 Years (Adult, Senior) |
NCT01819597 |
K23NS079477-01A1 |
ERSIAS |
March 2013 |
June 2018 |
June 2018 |
March 27, 2013 |
November 1, 2017 |
|
- Cedars Sinai Medical Center
Los Angeles, California, United States
|
| 41 |
NCT02561000 |
Recruiting |
Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention |
- Arterial Occlusive Diseases
- Coronary Artery Disease
- Coronary Disease
- (and 5 more...)
|
- Drug: PZ-128
- Drug: Placebo
|
Interventional |
Phase 2 |
- Tufts Medical Center
- National Heart, Lung, and Blood Institute (NHLBI)
- RTI International
- (and 2 more...)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Prevention
|
- Incidence of bleeding through 30 days following treatment in subjects undergoing cardiac catheterization/percutaneous coronary intervention
- Incidence of major adverse cardiac events
|
600 |
All |
18 Years and older (Adult, Senior) |
NCT02561000 |
TMC-PZ128-02
P50HL110789 |
TRIP-PCI |
April 2016 |
March 2019 |
June 2019 |
September 25, 2015 |
June 26, 2017 |
|
- Tufts Medical Center
Boston, Massachusetts, United States - UMass Memorial Medical Center
Worcester, Massachusetts, United States - Inova Heart and Vascular Institute, Inova Fairfax Hospital
Falls Church, Virginia, United States
|
| 42 |
NCT03405506 |
Not yet recruiting |
Functional Diagnostic Accuracy of Quantitative Flow Ratio in Tandem Lesions and Virtual Stenting |
- Coronary Artery Disease
- Cardiovascular Diseases
- Myocardial Ischemia
- (and 4 more...)
|
- Device: Quantitative Flow Ratio (QFR)
|
Observational |
|
- Pulse Medical Imaging Technology (Shanghai) Co., Ltd
- Shanghai Chest Hospital
|
Industry / Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Diagnostic accuracy of QFR in tandem lesions as compared with FFR prior to intervention
- Diagnostic accuracy of QFR-based virtual stenting in predicting FFR values after revascularizing the culprit lesion
|
69 |
All |
18 Years and older (Adult, Senior) |
NCT03405506 |
CARDIAC201701 |
FORTRESS |
February 2, 2018 |
February 2, 2019 |
February 2, 2019 |
January 23, 2018 |
January 23, 2018 |
|
- Shanghai Chest Hospital
Shanghai, Shanghai, China
|
| 43 |
NCT03116438 |
Not yet recruiting |
CADence Performance as a Rule-Out Modality in Long Beach Veterans Administration Heart Catheterization Lab Patients |
- Coronary Artery Disease
- Myocardial Ischemia
- Coronary Disease
- (and 5 more...)
|
|
Interventional |
Not Applicable |
- VA Long Beach Healthcare System
|
U.S. Fed |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
|
100 |
All |
40 Years and older (Adult, Senior) |
NCT03116438 |
1358-001 |
SOLDIER |
June 16, 2017 |
December 2017 |
January 2018 |
April 17, 2017 |
April 17, 2017 |
|
|
| 44 |
NCT02685098 |
Recruiting |
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation |
- Ischemia
- Peripheral Arterial Disease
- Peripheral Vascular Disease
- (and 8 more...)
|
- Biological: Allogeneic bone marrow derived mesenchymal stem cells
|
Interventional |
Phase 1 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Number of participants with treatment-related adverse events occurring during the enrollment period as assessed by the Investigator using the MeDRA scale.
- Gene and protein arrays, IHC staining, and multiparametric flow cytometry will measure the time period of retention of allogeneic MSCs in harvested human skeletal muscle tissue post-MSC implantation.
- Recruitment of proangiogenic hematopoietic cells into sites of ischemia will be measured and reported as assessed by the role of MSCs injected in human skeletal muscle at the time of below knee amputation.
|
16 |
All |
40 Years to 90 Years (Adult, Senior) |
NCT02685098 |
1505714405 |
CHAMP |
January 2017 |
September 2019 |
September 2019 |
February 18, 2016 |
August 9, 2017 |
|
- Indiana University
Indianapolis, Indiana, United States
|
| 45 |
NCT02931188 |
Recruiting |
The Effect of Anacetrapib on Vascular Function and Arterial Stiffness |
- Atherosclerotic Cardiovascular Disease
- Vascular Disease
|
- Drug: Anacetrapib
- Drug: Statin
- Drug: Placebo
|
Observational |
|
- Cambridge University Hospitals NHS Foundation Trust
- British Heart Foundation Cambridge Centre of Excellence
|
Other |
- Observational Model: Cohort
- Time Perspective: Cross-Sectional
|
- The effect of treatment on flow-mediated dilation (FMD)
- The effect of treatment on aortic (carotid-to-femoral) Pulse Wave Velocity (PWV)
- The effect of treatment on central blood pressure
- The effect of treatment on sublingual glyceryl trinitrate (GTN) response on artery dilation
|
130 |
All |
50 Years and older (Adult, Senior) |
NCT02931188 |
REVEAL-Vasc |
REVEAL-Vasc |
January 2017 |
September 2018 |
September 2018 |
October 12, 2016 |
June 26, 2017 |
|
- Clinical Investigation Ward, Addenbrooke's Hospital
Cambridge, Cambridgeshire, United Kingdom
|
| 46 |
NCT01848886 |
Recruiting |
Neurological Complications Comparing Endoscopically vs. Open Harvest of the Radial Artery |
- Complications Due to Coronary Artery Bypass Graft
- Coronary Artery Disease
- Myocardial Ischemia
- (and 6 more...)
|
- Procedure: Endoscopic radial artery harvest
- Procedure: Open radial artery harvest
- Procedure: Mammarioradial graft (Y-graft)
- Procedure: Aortoradial graft (Free RA)
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Factorial Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Sum score of hand function questionnaire
- Occurence of cardiac and cerebrovascular events in aortoradial versus mammarioradial grafting
- Complications in the donor arm in ERAH versus ORAH
- (and 2 more...)
|
300 |
All |
18 Years and older (Adult, Senior) |
NCT01848886 |
H-3-2012-116 |
NEO |
May 2013 |
May 2018 |
May 2019 |
May 8, 2013 |
July 6, 2016 |
|
- Rigshospitalet
Copenhagen, Denmark
|
| 47 |
NCT03252652 |
Not yet recruiting |
Normal Parameters of Cranial Vessels Using Cranial Vascular Duplex Among Egyptian Population |
- Atherosclerosis
- Atheroma of Cerebral Arteries
- Atheroma; Carotid Artery
- Atheroma; Cerebral
|
- Radiation: vascular duplex ultrasound imaging
|
Observational |
|
|
Other |
- Observational Model: Other
- Time Perspective: Cross-Sectional
|
- Normal intimal-medial thickness measured in millimeter
- Normal vessels' diameter measured in millimeter
- Normal peak flow velocity measured in cm/sec
- (and 2 more...)
|
100 |
All |
20 Years to 60 Years (Adult) |
NCT03252652 |
SNPCUETCDE |
|
October 2017 |
August 2019 |
October 2019 |
August 17, 2017 |
August 17, 2017 |
|
|
| 48 |
NCT02534545 |
Recruiting |
Remote Ischemic Conditioning for Avoiding Recurrence of Symptomatic Intracranial Atherosclerotic Stenosis (sICAS) |
- Intracranial Atherosclerosis
|
- Device: Doctormate® (200mmHg)
- Device: Doctormate® (60mmHg)
|
Interventional |
Not Applicable |
- Ji Xunming
- Capital Medical University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Prevention
|
- The time from randomization to the first occurrence of fatal or non-fatal ischemic stroke.
- The time from randomization to the first occurrence of a composite of fatal or non-fatal stroke (ischemic and hemorrhagic), fatal or non-fatal myocardial infarction, and transient ischemic attack (TIA) .
- The time from randomization to the first occurrence of each component of the composite of fatal or non-fatal stroke (ischemic and hemorrhagic), fatal or non-fatal myocardial infarction, and TIA.
- Time to death from all causes from randomization.
|
3000 |
All |
40 Years to 80 Years (Adult, Senior) |
NCT02534545 |
RICA |
|
September 2015 |
September 2018 |
September 2018 |
August 27, 2015 |
February 25, 2016 |
|
- Wuhu NO.2 People's Hospital
Wuhu, Anhui, China - The Hospital of Shunyi District Beijing
Beijing, Beijing, China - Beijing Huairou Hospital
Beijing, Beijing, China - (and 47 more...)
|
| 49 |
NCT03291392 |
Recruiting |
CUHK Stroke Biobank |
- Stroke, Ischemic
- Genetic Disease
- Atherosclerosis, Cerebral
|
- Genetic: Gene expression or biomarkers exploration
|
Observational |
|
- Chinese University of Hong Kong
|
Other |
- Observational Model: Other
- Time Perspective: Other
|
- Ischemic stroke-related genetics
|
500 |
All |
18 Years and older (Adult, Senior) |
NCT03291392 |
crec no. 2014.582 |
|
June 15, 2015 |
December 31, 2025 |
December 31, 2025 |
September 25, 2017 |
September 25, 2017 |
|
- Chinese University of Hong Kong
Hong Kong, Hong Kong
|
| 50 |
NCT00410241 |
Recruiting |
ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study |
- Cardiovascular Disease
- Coronary Artery Calcification
|
|
Observational |
|
- National Human Genome Research Institute (NHGRI)
- National Institutes of Health Clinical Center (CC)
|
NIH |
|
|
2000 |
All |
45 Years to 65 Years (Adult) |
NCT00410241 |
070002
07-HG-0002 |
|
December 8, 2006 |
|
|
December 12, 2006 |
April 17, 2018 |
|
- Suburban Hospital
Bethesda, Maryland, United States - National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
|
Create an RSS feed from your search for:
Download the search results for: